Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

610
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
610
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

627
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
627
Vaccinations01:51

Vaccinations

49.1K
Overview
49.1K
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

236
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
236
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

504
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
504
Fungal Phylum Basidiomycota01:26

Fungal Phylum Basidiomycota

518
Basidiomycota is a diverse phylum of fungi that includes ecologically significant decomposers such as white rot fungi, symbionts like mycorrhizal fungi, plant pathogens such as rusts and smuts, and edible species like Agaricus bisporus (the common button mushroom). These fungi play crucial roles in nutrient cycling, symbiotic relationships, and even human health. Their defining feature is the basidium, a microscopic club-shaped structure responsible for producing basidiospores.Fruiting Bodies...
518

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving health literacy and patient-directed knowledge of fecal microbiota transplantation (FMT) through analysis of readability: a cross-sectional infodemiology study.

Expert opinion on biological therapy·2025
Same author

Improving health literacy of passengers of cruise ships: readability of passenger-facing COVID-19 information provided by commercial cruise lines-an infodemiology study.

Journal of travel medicine·2024
Same author

Improving health literacy of antibiotic use in people with cystic fibrosis (CF)-comparison of the readability of patient information leaflets (PILs) from the EU, USA and UK of 23 CF-related antibiotics used in the treatment of CF respiratory infections.

JAC-antimicrobial resistance·2023
Same author

Improving health literacy of antifungal use-Comparison of the readability of antifungal medicines information from Australia, EU, UK, and US of 16 antifungal agents across 5 classes (allylamines, azoles, echinocandins, polyenes, and others).

Medical mycology·2023
Same author

Infection Dynamics of Aspergillus fumigatus in Adults with Cystic Fibrosis (CF).

Mycopathologia·2023
Same author

Improving health literacy with mumps, measles and rubella (MMR) vaccination: comparison of the readability of MMR patient-facing literature and MMR scientific abstracts.

Therapeutic advances in vaccines and immunotherapy·2022

Related Experiment Video

Updated: Nov 11, 2025

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.4K

Fungal vaccines.

H T Pattison1, B C Millar1,2, J E Moore1,2

  • 1School of Medicine, Dentistry and Biomedical Sciences, the Wellcome-Wolfson Institute for Experimental Medicine, Queen's University, Belfast, Northern Ireland, UK.

British Journal of Biomedical Science
|March 22, 2021
PubMed
Summary
This summary is machine-generated.

Antifungal resistance threatens treatment of invasive fungal disease. This review explores novel fungal vaccine strategies, focusing on Aspergillus antigens and techniques for immunocompromised patients.

Keywords:
AspergillusCFantifungal resistanceantimicrobial resistancefungal vaccineshaematological malignancy

More Related Videos

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model
06:02

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model

Published on: November 6, 2020

16.7K
Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

12.2K

Related Experiment Videos

Last Updated: Nov 11, 2025

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.4K
A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model
06:02

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model

Published on: November 6, 2020

16.7K
Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

12.2K

Area of Science:

  • Mycology
  • Immunology
  • Vaccinology

Background:

  • Invasive fungal infections pose significant life-threatening risks, especially in immunocompromised individuals with hematological malignancies.
  • Current antifungal drugs (azoles, echinocandins, polyenes) face emerging resistance, mirroring antibiotic resistance.
  • Developing effective fungal vaccines is crucial, but eliciting adequate immune responses in vulnerable populations remains a challenge.

Purpose of the Study:

  • To review current data on invasive fungal diseases and antifungal resistance.
  • To investigate potential Aspergillus antigens for vaccine development.
  • To explore feasible vaccine techniques for high-risk, immunocompromised populations.

Main Methods:

  • Literature review of recent data on fungal infections and antifungal resistance.
  • Assessment of potential Aspergillus antigens for immunogenicity.
  • Evaluation of vaccine delivery methods suitable for immunocompromised individuals.

Main Results:

  • Antifungal resistance is an increasing threat to treating invasive fungal infections.
  • Identifying suitable Aspergillus antigens is key for vaccine efficacy.
  • Adapting vaccine techniques is necessary for successful immunization of immunocompromised groups.

Conclusions:

  • Fungal vaccines offer a promising alternative to antifungal drugs, especially given rising resistance.
  • Targeting Aspergillus with novel vaccine strategies is essential for protecting high-risk groups.
  • Further research into vaccine techniques is needed to overcome challenges in immunocompromised patients.